New Market Study: "Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2012"
GlobalData's clinical trial report, "Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2012" provides data on the Focal Segmental Glomerulosclerosis (FSGS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Focal Segmental Glomerulosclerosis (FSGS). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence...
View full press release